The Latest Cardiac and Vascular News
NEW YORK, July 24, 2025 /PRNewswire/ — GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, today announced its IND Application to commence Global Phase 3 Clinical Trials of its lead drug Nelonemdaz, has been approved by MFDS – South Korea’s…
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and first patient cases with the latest advancement in ischemic stroke treatment – the novel Zoom 7X Catheter for aspiration thrombectomy procedures. The newest addition to the company’s comprehensive Zoom Stroke System, the Zoom 7X Catheter […]
Trial met primary endpoints of similar rates of serious adverse events (SAEs) and fewer deaths observed with RNS60 versus placebo Statistically significant reduction in infarct growth (brain tissue loss) – a secondary endpoint – in patients treated with RNS60 adjunct to endovascular…
Late-Breaking Data Presented at Society of NeuroInterventional Surgery Annual Meeting Demonstrate Excellent Reperfusion Results and Unparalleled Safety with the Zoom System for Ischemic Stroke CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced a late-breaking abstract with data from the Imperative Trial evaluating aspiration with the Zoom System in stroke patients with M2 […]
Real-World U.S. Physician Preference Data1 Demonstrates the SOFIA™ 88 Catheter’s Trackability, Atraumatic Design, and Overall Performance in Stroke Procedures NASHVILLE, Tenn., July 14, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned…
Company to Showcase Progress on Radical Catheter Portfolio and Best-in-Class Ribbon Technology Platform at Society of Neurointerventional Surgery Annual Meeting Company to Showcase Progress on Radical Catheter Portfolio and Best-in-Class Ribbon Technology Platform at Society of Neurointerventional Surgery Annual Meeting
Increasing rates of neurovascular interventions spark a need for reliable access and procedural versatility Company expands portfolio with a novel access catheter featuring a unique ID/OD ratio Purpose-built laser cut technology enables balanced delivery performance and stable support…
OXFORD, England and CHICAGO, Ill., June 24, 2025 /PRNewswire/ — Today, Brainomix, a pioneer in stroke artificial intelligence (AI) imaging solutions, and 3DR Labs, the market leader in medical imaging post-processing services, announced a new strategic partnership to support acute stroke…
BARCELONA – June 18, 2025 – ANACONDA Biomed, a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has announced that it has received CE Mark certification for its ANA5 Funnel Catheter. The CE marking confirms that the ANA5 device complies with the European Union’s health, […]
Lake Forest, CA – Crossroads Neurovascular, Inc. is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K242392) for its groundbreaking PATH BGC™, a next-generation balloon guide catheter (BGC) designed to advance neurovascular intervention. With this clearance, PATH BGC becomes the world’s first BGC […]
